Loading...
XHKG
0157
Market cap128mUSD
Nov 26, Last price  
0.50HKD
Name

Natural Beauty Bio-Technology Ltd

Chart & Performance

D1W1MN
XHKG:0157 chart
P/E
—
P/S
2.83
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-4.21%
Revenues
354m
+5.25%
357,916,000363,746,000450,147,000592,701,000538,092,000485,389,000591,295,000483,438,000439,421,000505,761,000506,913,000475,225,000399,579,000369,525,000438,413,000410,673,000487,810,000335,880,000336,015,000353,651,000
Net income
-104m
L+585.69%
81,011,000122,812,000178,707,000238,477,000149,636,00031,303,000115,123,000119,268,00058,269,00071,480,000136,830,000148,403,000105,388,00026,259,00021,908,0007,758,00035,264,000-30,472,000-15,111,000-103,615,000
CFO
-14m
L
111,678,000106,152,000274,198,000269,288,000154,091,000173,890,000170,374,00059,537,000108,289,000165,103,000140,084,000127,952,00021,176,00073,983,00020,316,00030,089,00042,781,0008,326,00021,724,000-13,746,000
Dividend
Jun 01, 20220.003 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Natural Beauty Bio-Technology Limited, an investment holding company, offers skin care products and services in in the People's Republic of China, Taiwan, and internationally. The company manufactures and sells skin care, beauty, aroma-therapeutic, cosmetics, health supplements, and make-up products under the Natural Beauty brand. It also offers skin treatment, beauty and spa, medical cosmetology, skin care consulting, and beauty consulting and training services. In addition, the company's spas provide hydrotherapy, facial treatment, body care, and skin care analysis services. Further, it engages in the wholesale of skin care and beauty products. The company was founded in 1976 and is based in Wan Chai, Hong Kong.
URL
http://www.ir-cloud.com/hongkong/00157/irwebsite/
IPO date
Mar 28, 2002
Employees
429
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT